Skip to content

Clinical trials

Myelodysplastic Syndromes trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myelodysplastic Syndromes Clear all

1,965 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
200033
200135
200246
200341
200445
200574
200670
200794
200889
200979
201076
201164
201264
201384
201473
201572
201683
201773
201877
201966
202080
202185
202272
202365
202472
202563
202657

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed964
Terminated322
Recruiting240
Unknown status160
Active, not recruiting119
Withdrawn83
Not yet recruiting39
Suspended19
Enrolling by invitation9
No longer available6
Available3
Approved for marketing1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
M.D. Anderson Cancer Center144
Fred Hutchinson Cancer Center62
National Cancer Institute (NCI)51
Memorial Sloan Kettering Cancer Center50
Celgene45
Masonic Cancer Center, University of Minnesota42
City of Hope Medical Center41
Novartis Pharmaceuticals36
National Heart, Lung, and Blood Institute (NHLBI)31
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins30

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myelodysplastic Syndromes1,965
Leukemia, Myeloid, Acute1,054
Leukemia573
Precursor Cell Lymphoblastic Leukemia-Lymphoma512
Leukemia, Myelomonocytic, Chronic363
Lymphoma, Non-Hodgkin338
Myeloproliferative Disorders333
Multiple Myeloma313
Lymphoma298
Leukemia, Lymphocytic, Chronic, B-Cell297

Trials

Showing 1 to 25 of 1,965. Each trial links to its page on Pharma Observatory.

1,865 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.